Quantum Biopharma (QNTM) EPS (Basic) (2019 - 2026)
Quantum Biopharma (QNTM) posted EPS (Basic) of -$0.62 for Q1 2026, up 11.06% sequentially from -$0.7 in Q4 2025, and up 52.71% YoY from -$0.41 in Q1 2025.
Quantum Biopharma (QNTM) EPS (Basic) (2019 - 2026) Analysis & Trends
Quantum Biopharma has reported EPS (Basic) for 8 years, with the latest figure at -$0.62 in Q1 2026.
- Quarterly EPS (Basic) rose 52.71% year-over-year to -$0.62 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.28 (up 47.83% YoY) and the FY2025 annual result came in at -$8.2, changed N/A from the prior year.
- EPS (Basic) grew to -$0.62 in Q1 2026 per QNTM's latest filing, from -$0.7 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.07 in Q2 2024 and troughed at -$953864.0 in Q2 2023.
- A 5-year average of -$80756.9 and a median of -$2.42 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) plunged 1886.93% in 2023, then jumped 100.0% in 2024.
- Over 5 years, EPS (Basic) stood at -$0.83 in 2022, then sank by 6810.48% to -$57.15 in 2023, then jumped by 91.6% to -$4.8 in 2024, then jumped by 85.41% to -$0.7 in 2025, then grew by 11.06% to -$0.62 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.62, -$0.7, and -$1.41 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.18 |
| 10 | Quantum Biopharma | 15.31 Mn | 11.66 Mn | - | -0.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.70 |
| Mar 31, 2026 | -0.62 |
| Dec 31, 2025 | -0.70 |
| Sep 30, 2025 | -1.41 |
| Jun 30, 2025 | -1.42 |
| Mar 31, 2025 | -1.32 |
| Dec 31, 2024 | -4.80 |
| Sep 30, 2024 | -4.17 |
| Jun 30, 2024 | -0.07 |
| Mar 31, 2024 | -3.41 |
| Dec 31, 2023 | -57.15 |
| Sep 30, 2023 | -176,639.67 |
| Jun 30, 2023 | -953,864.00 |
| Mar 31, 2023 | -16.43 |
| Mar 31, 2022 | -0.83 |
| Jun 30, 2021 | -41,176.09 |
| Mar 31, 2021 | 1.29 |
| Sep 30, 2020 | -5.96 |
| Jun 30, 2020 | -2.94 |
| Mar 31, 2020 | -7.15 |